{"id":"W4295787604","doi":"10.1172/jci160565","title":"Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"National Institutes of Health; AstraZeneca; National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation; Pfizer; Gilead Sciences; BioFire Diagnostics; Sanofi","keywords":"Medicine; Vaccination; Placebo; Incidence (geometry); Clinical endpoint; Immunogenicity; Coronavirus disease 2019 (COVID-19); Randomized controlled trial; Internal medicine; Vaccine efficacy; Immunology; Antibody; Disease; Infectious disease (medical specialty); Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002842902,0.0002741152,0.0006289791,0.0002435468,0.0001977231,0.0003465875,0.0002296593,0.0002955615,0.002206761],"category_scores_gemma":[0.001838817,0.0001510923,0.0004802064,0.0001624431,0.0001958585,0.000502852,0.0001703135,0.0006512474,0.0003122447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002364925,"about_ca_system_score_gemma":0.0002123609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003762482,"about_ca_topic_score_gemma":0.0004247378,"domain_scores_codex":[0.9993153,0.0001958978,0.00005753061,0.0001227538,0.0001624485,0.0001461181],"domain_scores_gemma":[0.9986123,0.0002803247,0.0006136798,0.0001236343,0.0001583047,0.0002117189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.193305,0.00770313,0.3470166,0.0009372082,0.002156456,0.0003568687,0.0004783029,0.002962842,0.1409385,0.000246205,0.003689208,0.3002096],"study_design_scores_gemma":[0.005562782,0.1242414,0.8281786,0.00006473672,0.001019792,0.0008308639,0.0001123832,0.001547767,0.03350846,0.0001969941,0.004690994,0.00004526779],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960802,0.00222233,0.0002818331,0.00007200645,0.00002334644,0.00004614918,0.000579014,0.00001555913,0.0006794655],"genre_scores_gemma":[0.9985132,0.0002538113,0.0001175148,0.00005331546,0.00002706546,0.00003701033,0.000591072,0.000003499991,0.0004035766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002842902,"threshold_uncertainty_score":0.01503491,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1463791873936612,"score_gpt":0.4418226302503966,"score_spread":0.2954434428567354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}